i10 Productivity
Rankings
Johnson & Johnson Co. 87 Scientists Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences i10 Productivity Rankings - 2025
Total 2,393,106 scientists, country 221, and institutions 24,447 are evaluated in the Productivity Rankings, an exclusive service provided by AD Scientific Index. This ranking measures and highlights the scientific productivity of researchers based on the i10 index (number of publications with at least 10 citations). This system identifies highly productive scientists across disciplines, institutions, and regions, contributing to the development of evidence-based academic policies and effective incentive mechanisms. The rankings include global, regional, and institutional analyses, along with specialized rankings such as Scientists' Last 6 Years' i10 Index and Universities' i10 Index Rankings 2025. With Premium Membership, you can:
- Gain full access to detailed comparisons and advanced analytics,
- Objectively evaluate your academic productivity,
- Make strategic, data-driven decisions to enhance performance.
* Total i10 IndexRankings
Ranking Based On Selection: 1
pharmacokinetics/pharmacodynamics
drug-drug interaction
MIDD
QSP
clinical pharmacology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
105
67
0.638
* Total i10 IndexRankings
Ranking Based On Selection: 2
Clinical Pharmacology
Pharmacometrics
Drug Development
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
95
43
0.453
* Total i10 IndexRankings
Ranking Based On Selection: 3
Drug transporters
Drug-Drug Interactions
Enzyme Induction
Drug-Induced Liver Injury
ADME
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
89
61
0.685
* Total i10 IndexRankings
Ranking Based On Selection: 4
clinical pharmacology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
78
31
0.397
* Total i10 IndexRankings
Ranking Based On Selection: 5
Clinical Pharmacology
Pharmaceutics
Drug Development
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
74
33
0.446
* Total i10 IndexRankings
Ranking Based On Selection: 6
Early development clinical trial design
Biomarkers
Statistical bio-informatics
omics data analysis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
53
24
0.453
* Total i10 IndexRankings
Ranking Based On Selection: 7
Drug Discovery
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
49
20
0.408
* Total i10 IndexRankings
Ranking Based On Selection: 8
Diabetes
CNS
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
47
36
0.766
* Total i10 IndexRankings
Ranking Based On Selection: 9
health economics
epidemiology
real world evidence
outcomes research
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
47
16
0.340
* Total i10 IndexRankings
Ranking Based On Selection: 10
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
46
32
0.696
Enroll all your faculty members with discounted institutional membership to showcase your institution's academic strength to the world in the best way possible – join now and achieve results fast!
* Total i10 IndexRankings
Ranking Based On Selection: 11
cardiovascular
metabolic disease
RWE
digital health
thrombosis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
46
18
0.391
* Total i10 IndexRankings
Ranking Based On Selection: 12
drug development
PK/PD model
QSP
clinical pharmacology
therapeutic biologics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
45
38
0.844
* Total i10 IndexRankings
Ranking Based On Selection: 13
Gene Therapy and Gene Delivery
Drug Discovery
T-cell Engagers
Immuno-Oncology
Protein Engineering
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
43
33
0.767
* Total i10 IndexRankings
Ranking Based On Selection: 14
Pharmaceutical Sciences
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
42
39
0.929
* Total i10 IndexRankings
Ranking Based On Selection: 15
Clinical Pharmacology & Pharmacometrics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
42
30
0.714
* Total i10 IndexRankings
Ranking Based On Selection: 16
Pharmacology
Pharmaceutics
Surgical Medical Devices
Genomics
Statistics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
39
24
0.615
* Total i10 IndexRankings
Ranking Based On Selection: 17
Pharmacokinetics
Drug Metabolism
PK PD
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
38
34
0.895
* Total i10 IndexRankings
Ranking Based On Selection: 18
Cancer Research
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
37
34
0.919
* Total i10 IndexRankings
Ranking Based On Selection: 19
CAR-T
Cell Therapy
Gene Editing
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
37
17
0.459
* Total i10 IndexRankings
Ranking Based On Selection: 20
statistical genetics
precision medicine
fibrosis
oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
36
25
0.694
* Total i10 IndexRankings
Ranking Based On Selection: 21
Clinical Pharmacology and Pharmacometrics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
35
28
0.800
* Total i10 IndexRankings
Ranking Based On Selection: 22
Pharmacoepidemiology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
33
28
0.848
* Total i10 IndexRankings
Ranking Based On Selection: 23
Protiomics
Post translational modification
Drug discovery
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
33
24
0.727
* Total i10 IndexRankings
Ranking Based On Selection: 24
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
33
16
0.485
* Total i10 IndexRankings
Ranking Based On Selection: 25
Oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
32
24
0.750
Honghui Zhou
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
105
67
0.638
pharmacokinetics/pharmacodynamics
drug-drug interaction
MIDD
QSP
clinical pharmacology
Juan Jose Perez Ruixo|JJ Perez-Ruixo, JJP Ruixo
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
95
43
0.453
Clinical Pharmacology
Pharmacometrics
Drug Development
Raymond Evers
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
89
61
0.685
Drug transporters
Drug-Drug Interactions
Enzyme Induction
Drug-Induced Liver Injury
ADME
İtalo Poggesi
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
78
31
0.397
Amarnath Sharma
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
74
33
0.446
Clinical Pharmacology
Pharmaceutics
Drug Development
Willem Talloen
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
53
24
0.453
Early development clinical trial design
Biomarkers
Statistical bio-informatics
omics data analysis
Gunaretnam Rajagopal
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
49
20
0.408
Jack Sheehan
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
47
36
0.766
Shane Kavanagh
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
47
16
0.340
health economics
epidemiology
real world evidence
outcomes research
Wim Van Der Elst
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
46
32
0.696
Enroll all your faculty members with discounted institutional membership to showcase your institution's academic strength to the world in the best way possible – join now and achieve results fast!
Tc Sarich
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
46
18
0.391
cardiovascular
metabolic disease
RWE
digital health
thrombosis
Weirong Wang
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
45
38
0.844
drug development
PK/PD model
QSP
clinical pharmacology
therapeutic biologics
Justin Scheer
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
43
33
0.767
Gene Therapy and Gene Delivery
Drug Discovery
T-cell Engagers
Immuno-Oncology
Protein Engineering
Yue Guo
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
42
39
0.929
Pharmaceutical Sciences
Mahesh N Samtani
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
42
30
0.714
Clinical Pharmacology & Pharmacometrics
Jeffrey W Clymer
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
39
24
0.615
Pharmacology
Pharmaceutics
Surgical Medical Devices
Genomics
Statistics
Ranjeet Dash
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
38
34
0.895
Pharmacokinetics
Drug Metabolism
PK PD
Michela Capello
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
37
34
0.919
John Lee
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
37
17
0.459
CAR-T
Cell Therapy
Gene Editing
Bevan Emma Huang
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
36
25
0.694
statistical genetics
precision medicine
fibrosis
oncology
Jong Bong Lee
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
35
28
0.800
Clinical Pharmacology and Pharmacometrics
James Weaver
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
33
28
0.848
Weixuan Chen
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
33
24
0.727
Protiomics
Post translational modification
Drug discovery
Jamese Hilliard
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
33
16
0.485
Ivo Cornelissen
Johnson & Johnson Co.
New Jersey, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
32
24
0.750